Today: 30 April 2026
Bradesco stock jumps in New York as Brazil inflation hits target ceiling and rate decision looms

Bradesco stock jumps in New York as Brazil inflation hits target ceiling and rate decision looms

New York, January 27, 2026, 11:00 EST — Regular session

  • Shares of Banco Bradesco (BBD) climbed roughly 4.5% in U.S. trading, following the upward trend seen among Brazilian bank ADRs
  • Brazil’s IPCA-15 inflation preview jumps to 4.50% year-on-year, hitting the upper limit of the target band
  • All eyes are on Wednesday’s Copom decision and Bradesco’s earnings report due February 5

Shares of Banco Bradesco, traded in New York, climbed around 4.5% to hit $4.15 on Tuesday, reaching that level during the session. Itau Unibanco’s ADRs advanced about 4.7%, while Santander Brasil rose close to 3.5%.

The shift comes as investors adjust Brazil rate expectations following fresh inflation figures, with the central bank set to announce its policy decision on Wednesday, January 28. Brazil’s IPCA-15 inflation preview jumped 0.20% in January, pushing the 12-month rate up to 4.50%, hitting the top of the target range. The IPCA-15 is a mid-month indicator that offers an early glimpse of official inflation.

William Jackson, chief emerging markets economist at Capital Economics, said the recent inflation uptick probably erased “lingering expectations” for an immediate rate cut at this week’s Copom meeting. Still, he anticipates easing will begin in March. Capital Economics

IBGE data revealed a mixed bag beneath the surface. Prices for food consumed at home ticked up 0.21%, snapping a seven-month streak of declines. The food and beverages category sped up to 0.31%, up from 0.13% in December. Meanwhile, São Paulo saw a slight dip, with its reading dropping 0.04%.

Traders are focused less on today’s data release and more on the central bank’s messaging. The market has mostly priced in a Selic rate cut for March, now turning its attention to how low rates might fall by late 2026, according to Broadcast. Carla Argenta, CM Capital’s chief economist, said a clear signal for cuts this week seems unlikely. BTG Pactual partner and chief economist Mansueto Almeida, however, expects there could be room for a 25-basis-point cut as soon as Wednesday.

Brazil’s major banks frequently move in step with interest rate shifts. Falling borrowing costs tend to boost credit demand and relieve stress on borrowers. At the same time, the trajectory of rate cuts can alter the margins they earn on loans and deposits.

Bradesco has a key event coming up fast. The bank will report its fourth-quarter earnings on February 5, right after markets close, followed by a conference call on February 6.

The rate trade can flip quickly. Should policymakers signal a hawkish stance—meaning tighter policy—due to persistent inflation or worries over election-year currency volatility, the surge in Brazilian financials could vanish just as fast as it showed up.

U.S. rates are lurking in the background. A sudden surge in Treasury yields can overshadow local stories, rattling emerging-market assets through shifts in currencies and risk appetite.

Stock Market Today

  • KalVista Pharmaceuticals Rises 39% on Acquisition Deal with Chiesi Group
    April 29, 2026, 6:37 PM EDT. KalVista Pharmaceuticals surged 38.62% to $26.67 after announcing its acquisition by Italy's Chiesi Group at $27 per share in cash. The deal sparked high trading volume, reaching 69.4 million shares, over 3,000% above average. KalVista, known for its oral therapy EKTERLY for hereditary angioedema, could benefit from Chiesi's global reach. The broader market was mixed: the S&P 500 dipped 0.02% to 7,138, while the Nasdaq edged up 0.04% to 24,673. Rival biotech stock Prothena dropped 5.56% amid investor caution over drug pipelines. KalVista's acquisition marks a shift for a company that faced heavy short interest and revenue challenges, positioning it for growth under Chiesi's ownership, pending regulatory approval.

Latest article

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

30 April 2026
Markel Group posted a $212.3 million net loss for the first quarter, driven by a $728 million investment loss, sending shares down 7.9% to $1,759.21. Operating revenue held steady at $3.55 billion, while adjusted operating income rose 4% to $498 million. Markel Insurance’s adjusted operating income jumped 31% to $369 million. Gross premium volume in underwriting fell 21% after exiting Global Reinsurance.
QQQ Rises Today as Big Tech Earnings Put the Nasdaq 100 Rally on the Line

QQQ Rises Today as Big Tech Earnings Put the Nasdaq 100 Rally on the Line

30 April 2026
The Invesco QQQ Trust closed up $3.99 at $661.57 Wednesday as investors positioned ahead of earnings from Microsoft, Alphabet, Amazon, and Meta. Volume topped 30 million shares. Microsoft and Alphabet reported strong cloud and AI-driven revenue growth after the bell. The broader Nasdaq Composite edged up 0.04%, while the S&P 500 slipped 0.04%.
Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps
Previous Story

Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps

BigBear.ai stock ticks up as BBAI traders brace for dilution vote deadline
Next Story

BigBear.ai stock ticks up as BBAI traders brace for dilution vote deadline

Go toTop